Any method to help detect psuedotumors earlier is an important step forward in helping those suffering complications from metal-on-metal hip replacements.
New York, New York (PRWEB) April 25, 2013
Bernstein Liebhard LLP notes that new study has found that early detection of metal-on-metal hip replacement complications could be possible via ultrasound. The research, which was presented last month at the Hip Society Specialty Day Meeting in Chicago, included 40 all-metal hip patients – 28 men and 12 women – who had undergone both ultrasounds and metal artifact reduction sequence (MARS) MRI. Both tests performed equally as well in detecting pseudotumors, a common metal-on-metal hip implant complication. However, a cost analysis showed a savings between $250,000 and $750,000 for every 100,000 patients that were screened via ultrasound instead of MARS.*
“Any method to help detect psuedotumors earlier is an important step forward in helping those suffering complications from metal-on-metal hip replacements. This study also highlights the exorbitant costs these problematic medical devices have levied on our health care system,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently representing clients in several metal-on-metal hip replacement litigations, and continues to offer free legal evaluations to alleged victims of these devices.
Metal-on-Metal Hip Implant Lawsuits
Metal-on-metal hip implants have been the subject of safety concerns since the August 2010 DePuy ASR hip recall.** In 2011, the U.S. Food & Drug Administration (FDA) embarked on a safety review of all-metal hips, amid concerns that metal ions shed from such devices could lead to serious complications, including the formation of psuedotumors, metallosis, and early device failure. In January, the agency issued new guidance for patients fitted with such devices, advising doctors to consider metal ion testing in those experiencing symptoms of hip implant failure. The FDA also said it had proposed a new rule that would make all-metal hips ineligible for the agency’s 510(k) clearance process, which allowed such devices to come to market without human testing.***
Bernstein Liebhard LLP is representing hundreds of alleged victims of the DePuy ASR hip recall in a multidistrict litigation now underway in U.S. District Court, Northern District of Ohio. Court filings indicate the litigation’s first trials will begin in June. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197) Firm partner, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committee for a second multidistrict litigation established in U.S. District Court, Northern District of Texas for metal-on-metal DePuy Pinnacle hip replacement lawsuits. (In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation - MDL No. 2244)
In addition, Bernstein Liebhard LLP is representing clients fitted with the Biomet M2a Magnum hip implant in a multidistrict litigation underway in U.S. District Court, Northern District of Indiana (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391). The Firm has also filed lawsuits on behalf of individuals affected by the Stryker hip recall for Rejuvenate and ABG II hip stems in a multicounty litigation now moving forward in New Jersey Superior Court. (In re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
Victims of alleged metal-on-metal hip replacement complications, including pseudotumors, metallosis or early device failure, may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about filing a metal-on-metal hip implant lawsuit is available on Bernstein Liebhard LLP’s website. For additional information, please contact one of our attorneys by calling 877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP